Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 178

1.

Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis.

Hasan R, Sharma R, Saraya A, Chattopadhyay TK, DattaGupta S, Walfish PG, Chauhan SS, Ralhan R.

BMC Cancer. 2014 Jan 2;14:2. doi: 10.1186/1471-2407-14-2.

PMID:
24383423
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Slug is a predictor of poor prognosis in esophageal squamous cell carcinoma patients.

Hasan MR, Sharma R, Saraya A, Chattopadhyay TK, DattaGupta S, Walfish PG, Chauhan SS, Ralhan R.

PLoS One. 2013 Dec 18;8(12):e82846. doi: 10.1371/journal.pone.0082846. eCollection 2013.

PMID:
24367561
[PubMed - in process]
Free PMC Article
3.

The adenovirus 55 residue E1A protein is a transcriptional activator and binds the unliganded thyroid hormone receptor.

Arulsundaram VD, Webb P, Yousef AF, Pelka P, Fonseca GJ, Baxter JD, Walfish PG, Mymryk JS.

J Gen Virol. 2014 Jan;95(Pt 1):142-52. doi: 10.1099/vir.0.056838-0. Epub 2013 Oct 17.

PMID:
24136366
[PubMed - indexed for MEDLINE]
4.

S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.

Kaur J, Matta A, Kak I, Srivastava G, Assi J, Leong I, Witterick I, Colgan TJ, Macmillan C, Siu KW, Walfish PG, Ralhan R.

Int J Cancer. 2014 Mar 15;134(6):1379-88. doi: 10.1002/ijc.28473. Epub 2013 Oct 8.

PMID:
24122701
[PubMed - indexed for MEDLINE]
5.

Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence.

Assi J, Srivastava G, Matta A, Chang MC, Walfish PG, Ralhan R.

PLoS One. 2013 Sep 13;8(9):e74437. doi: 10.1371/journal.pone.0074437. eCollection 2013.

PMID:
24058567
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Clinical significance of altered expression of ╬▓-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.

Kaur J, Sawhney M, DattaGupta S, Shukla NK, Srivastava A, Walfish PG, Ralhan R.

PLoS One. 2013 Jun 28;8(6):e67361. doi: 10.1371/journal.pone.0067361. Print 2013.

PMID:
23840677
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas.

Chaker S, Kashat L, Voisin S, Kaur J, Kak I, MacMillan C, Ozcelik H, Siu KW, Ralhan R, Walfish PG.

Proteomics. 2013 Mar;13(5):771-87. doi: 10.1002/pmic.201200356.

PMID:
23319340
[PubMed - indexed for MEDLINE]
8.

Iodine nutrition during pregnancy in Toronto, Canada.

Katz PM, Leung AM, Braverman LE, Pearce EN, Tomlinson G, He X, Vertes J, Okun N, Walfish PG, Feig DS.

Endocr Pract. 2013 Mar-Apr;19(2):206-11. doi: 10.4158/EP12193.OR.

PMID:
23186967
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.

Kunavisarut T, Kak I, Macmillan C, Ralhan R, Walfish PG.

BMC Cancer. 2012 Nov 15;12:523. doi: 10.1186/1471-2407-12-523.

PMID:
23153310
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Activated leukocyte cell adhesion molecule is a marker for thyroid carcinoma aggressiveness and disease-free survival.

Chaker S, Kak I, MacMillan C, Ralhan R, Walfish PG.

Thyroid. 2013 Feb;23(2):201-8. doi: 10.1089/thy.2012.0405.

PMID:
23148625
[PubMed - indexed for MEDLINE]
11.

An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma.

He HC, Kashat L, Kak I, Kunavisarut T, Gundelach R, Kim D, So AK, MacMillan C, Freeman JL, Ralhan R, Walfish PG.

PLoS One. 2012;7(9):e42893. doi: 10.1371/journal.pone.0042893. Epub 2012 Sep 25.

PMID:
23049733
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Biotinidase is a novel marker for papillary thyroid cancer aggressiveness.

So AK, Kaur J, Kak I, Assi J, MacMillan C, Ralhan R, Walfish PG.

PLoS One. 2012;7(7):e40956. doi: 10.1371/journal.pone.0040956. Epub 2012 Jul 23.

PMID:
22911723
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Radioiodine ablation in low-risk thyroid cancer.

Orlov S, Freeman JL, Walfish PG.

N Engl J Med. 2012 Aug 16;367(7):672; author reply 673-5. doi: 10.1056/NEJMc1206712#SA1. No abstract available.

PMID:
22894582
[PubMed - indexed for MEDLINE]
14.

Predictive value of metastatic cervical lymph node ratio in papillary thyroid carcinoma recurrence.

Yip J, Orlov S, Orlov D, Vaisman A, Hernández KG, Etarsky D, Kak I, Parvinnejad N, Freeman JL, Walfish PG.

Head Neck. 2013 Apr;35(4):592-8. doi: 10.1002/hed.23047. Epub 2012 Jun 23.

PMID:
22730192
[PubMed - indexed for MEDLINE]
15.

Stimulated thyroglobulin and neck ultrasonography facilitates postsurgical radioactive iodine remnant ablation selection in patients with low-risk well-differentiated thyroid carcinoma.

Gomez Hernandez K, Etarsky D, Orlov S, Walfish PG.

Thyroid. 2012 Jul;22(7):760-1. doi: 10.1089/thy.2011.0453. Epub 2012 Jun 4. No abstract available.

PMID:
22663549
[PubMed - indexed for MEDLINE]
16.

Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers.

Ralhan R, He HC, So AK, Tripathi SC, Kumar M, Hasan MR, Kaur J, Kashat L, MacMillan C, Chauhan SS, Freeman JL, Walfish PG.

PLoS One. 2010 Nov 30;5(11):e14130. doi: 10.1371/journal.pone.0014130.

PMID:
21152431
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Thyroid pathophysiology: reflections on physician-scientist careers in thyroidology.

Walfish PG.

Thyroid. 2010 Nov;20(11):1201-4. doi: 10.1089/thy.2010.1661. No abstract available.

PMID:
21062192
[PubMed - indexed for MEDLINE]
18.

Secretome-based identification and characterization of potential biomarkers in thyroid cancer.

Kashat L, So AK, Masui O, Wang XS, Cao J, Meng X, Macmillan C, Ailles LE, Siu KW, Ralhan R, Walfish PG.

J Proteome Res. 2010 Nov 5;9(11):5757-69. doi: 10.1021/pr100529t. Epub 2010 Oct 15.

PMID:
20873772
[PubMed - indexed for MEDLINE]
19.

EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis.

Ralhan R, Cao J, Lim T, Macmillan C, Freeman JL, Walfish PG.

BMC Cancer. 2010 Jun 25;10:331. doi: 10.1186/1471-2407-10-331.

PMID:
20579375
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.

Vaisman A, Orlov S, Yip J, Hu C, Lim T, Dowar M, Freeman JL, Walfish PG.

Head Neck. 2010 Jun;32(6):689-98. doi: 10.1002/hed.21371.

PMID:
20187016
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk